Terms of Use

Last Updated: October 18, 2026

These Terms of Use ("Terms") apply to the RheumCompanion mobile application (the "App") and the website www.rheumcompanion.com. RheumCompanion is published by Wickersham Development Group, LLC ("we", "us"). By downloading or using the App or the website, you agree to these Terms and to our Privacy Policy. If you do not agree, please do not use them.

1. Not medical advice

RheumCompanion is an educational and personal health record tool. It is not a medical device, and it does not provide medical advice, diagnosis or treatment recommendations. Always consult your rheumatologist or another qualified health provider about your care. Never delay seeking medical advice because of something you read in the App. If you think you may have a medical emergency, call your doctor or emergency services right away.

2. AI-generated answers

RheumBot answers and drug interaction explanations are generated by artificial intelligence. They can be incomplete, out of date or wrong, even when sources are shown. Treat them as a starting point for a conversation with your care team, not as a decision. Check the cited sources, and do not start, stop or change a medication based on the App alone.

3. Who can use the App

The App is intended for adults. You must be at least 18 years old to use it.

4. Subscriptions and free trial

5. Your data and your device

Your record is stored on your device, as described in the Privacy Policy. We do not keep a copy. You are responsible for your device's security and for making your own backups with the App's export features. If you delete the App or its data, your record cannot be recovered by us.

6. Acceptable use

You agree to use the App and website only for personal, lawful purposes. You agree not to copy, resell or redistribute the App or its content; not to reverse engineer it except where the law allows; and not to misuse its online features, for example by sending automated or excessive requests to RheumBot or trying to get around the App's limits.

7. Ownership

The App, the website and their content are owned by us or our licensors. We grant you a personal, non-transferable license to use the App on devices you own or control while these Terms are in effect. Information drawn from public sources, such as FDA drug labels, PubMed and ClinicalTrials.gov, remains subject to the terms of those sources.

8. Third-party services

The App relies on third-party services, including Apple, Google, RevenueCat, Cloudflare and U.S. government databases. The website links to the App Store, Google Play, Amazon and other sites. Those services and sites have their own terms, and we are not responsible for them.

9. Disclaimer of warranties

To the fullest extent the law allows, the App and the website are provided "as is" and "as available", without warranties of any kind, whether express or implied, including warranties of accuracy, fitness for a particular purpose and non-infringement. We do not promise that the App will be uninterrupted, error-free or always available.

10. Limitation of liability

To the fullest extent the law allows, we are not liable for any indirect, incidental, special, consequential or punitive damages, or for any loss of data, arising from your use of the App or the website. Our total liability for any claim relating to them is limited to the amount you paid for the App in the 12 months before the claim. Some places do not allow these limits, so they may not apply to you.

11. Apple and Google

These Terms are between you and us, not Apple or Google. If you downloaded the App from the App Store, Apple's Licensed Application End User License Agreement also applies. Where it conflicts with these Terms, Apple's agreement controls for the iOS App. If you downloaded the App from Google Play, the Google Play Terms of Service also apply to your purchase.

12. Changes to these Terms

We may update these Terms from time to time. Any changes will be posted on this page with an updated "Last Updated" date. Continuing to use the App after a change means you accept the updated Terms.

13. Contact us

If you have any questions about these Terms, please contact the developer:

Wickersham Development Group, LLC
Email: penn@wickershamdevgrp.com